Log in to save to my catalogue

PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip...

PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_098f549e562440f1980394c9d9c3365b

PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis

About this item

Full title

PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis

Publisher

London: BioMed Central Ltd

Journal title

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.50-50, Article 50

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Altered glucose metabolism endows tumor cells with metabolic flexibility for biosynthesis requirements. Phosphoenolpyruvate carboxykinase 1 (PCK1), a key enzyme in the gluconeogenesis pathway, is downregulated in hepatocellular carcinoma (HCC) and predicts poor prognosis. Overexpression of PCK1 has been shown to suppress liver tumor grow...

Alternative Titles

Full title

PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_098f549e562440f1980394c9d9c3365b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_098f549e562440f1980394c9d9c3365b

Other Identifiers

ISSN

1756-9966,0392-9078

E-ISSN

1756-9966

DOI

10.1186/s13046-019-1029-y

How to access this item